SAN DIEGO—A monthly injection of octreotide may reduce the need for both transfusions and endoscopies in patients with anemia caused by gastrointestinal angiodysplasia, according to data from a multicenter randomized trial.
The benefits were substantial and the treatment was relatively well tolerated, according to investigator Lia Goltstein, MD, a PhD candidate in the Department of Gastroenterology at Radboud University Medical Center, in Nijmegen, the Netherlands.
Over a one-year study